Efficacy of targeting bone-specific GIP receptor in ovariectomy-induced bone loss

DocumentFichier
Fichier pdf chargé le 05/10/2018 à 11:38:07
Accès libre
(version auteur)
fichier
TitreEfficacy of targeting bone-specific GIP receptor in ovariectomy-induced bone loss
Type de publicationArticle de revue
AuteurMabilleau, Guillaume , Gobron, Benoit , Mieczkowska, Aleksandra , Perrot, Rodolphe , Chappard, Daniel
EditeurBioScientifica
TypeArticle scientifique dans une revue à comité de lecture
Année2018
LangueAnglais
Date18 Août 2018
Titre de la revueJournal of endocrinology
ISSN1479-6805
Résumé en anglais

Glucose-dependent insulinotropic polypeptide (GIP) has been recognized in the last decade as an important contributor of bone remodeling and is necessary for optimal bone quality. However, GIP receptors are expressed in several tissues in the body and little is known about the direct versus indirect effects of GIP on bone remodeling and quality. The aims of the present study were to validate two new GIP analogues, called [D-Ala2]-GIP-Tag and [D-Ala2]-GIP1-30, that specifically target either bone or whole body GIP receptors, respectively; and to ascertain the beneficial effects of GIP therapy on bone in a mouse model of ovariectomy-induced bone loss. Both GIP analogues exhibited similar binding capacities at the GIP receptor and intracellular responses as full-length GIP1-42. Furthermore, only [D-Ala2]-GIP-Tag, but not [D-Ala2]-GIP1-30, was undoubtedly found exclusively in the bone matrix and released at acidic pH. In ovariectomized animals, [D-Ala2]-GIP1-30 but not [D-Ala2]-GIP-Tag ameliorated bone stiffness at the same magnitude than alendronate treatment. Only [D-Ala2]-GIP1-30 treatment led to significant ameliorations in cortical microarchitecture. Although alendronate treatment increased the hardness of the bone matrix and the type B carbonate substitution in the hydroxyapatite crystals, none of the GIP analogues modified bone matrix composition. Interestingly, in ovariectomy-induced bone loss, [D-Ala²]-GIP-Tag failed to alter bone strength, microarchitecture and bone matrix composition. Overall, this study shows that the use of a GIP analogue that target whole body GIP receptors might be useful to improve bone strength in ovariectomized animals.

URL de la noticehttp://okina.univ-angers.fr/publications/ua17658
DOI10.1530/JOE-18-0214
Lien vers le document

https://joe.bioscientifica.com/view/journals/joe/aop/joe-18-0214.xml

Autre titreJ. Endocrinol.
Identifiant (ID) PubMed30121578